These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35924779)

  • 21. University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (morning panel session).
    Davis B; Kerr D; Maguire M; Sanders C; Snapinn S; Wittes J
    Clin Trials; 2018 Aug; 15(4):335-351. PubMed ID: 30021495
    [No Abstract]   [Full Text] [Related]  

  • 22. Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issues.
    Wang SJ
    J Biopharm Stat; 2010 Nov; 20(6):1090-7. PubMed ID: 21058104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond.
    Moher D; Altman DG; Schulz KF; Elbourne DR
    CMAJ; 2004 Aug; 171(4):349-50. PubMed ID: 15313995
    [No Abstract]   [Full Text] [Related]  

  • 24. Statistical methods for the meta-analysis of cluster randomization trials.
    Donner A; Piaggio G; Villar J
    Stat Methods Med Res; 2001 Oct; 10(5):325-38. PubMed ID: 11697225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical power in three-arm cluster randomized trials.
    Liu XS
    Eval Health Prof; 2014 Dec; 37(4):470-87. PubMed ID: 23908381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?
    Ellenberg SS; Ellenberg JH
    Clin Trials; 2017 Oct; 14(5):415-416. PubMed ID: 28776406
    [No Abstract]   [Full Text] [Related]  

  • 27. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key Issues in the Statistical Interpretation of Randomized Clinical Trials.
    Brophy JM
    Can J Cardiol; 2021 Sep; 37(9):1312-1321. PubMed ID: 33359356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical issues in assessing powered toothbrushes.
    Boardman TJ
    Adv Dent Res; 2002 May; 16(1):4-5; discussion 22. PubMed ID: 12161386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in the Design and Interpretation of Noninferiority Trials.
    Mauri L; D'Agostino RB
    N Engl J Med; 2017 Oct; 377(14):1357-1367. PubMed ID: 28976859
    [No Abstract]   [Full Text] [Related]  

  • 31. Meta-analysis of cluster-randomized trials.
    Spineli LM; Pandis N
    Am J Orthod Dentofacial Orthop; 2023 Feb; 163(2):288-291. PubMed ID: 36710062
    [No Abstract]   [Full Text] [Related]  

  • 32. University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (morning panel discussion).
    Daniels M; Frangakis C; Charu V; Ghosh D
    Clin Trials; 2015 Aug; 12(4):323-32. PubMed ID: 26062596
    [No Abstract]   [Full Text] [Related]  

  • 33. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

  • 34. Stepped-wedge cluster-randomised trials: level of evidence, feasibility and reporting.
    Haines TP; Hemming K
    J Physiother; 2018 Jan; 64(1):63-66. PubMed ID: 29289591
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings of the University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation for clinical trials.
    Ellenberg JH; Ellenberg SS
    Clin Trials; 2013 Oct; 10(5):645-6. PubMed ID: 24130199
    [No Abstract]   [Full Text] [Related]  

  • 36. Panel discussion 1.
    Dickersin K; Williams G; George S
    Clin Trials; 2012 Dec; 9(6):696-704. PubMed ID: 23250943
    [No Abstract]   [Full Text] [Related]  

  • 37. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation (Morning Session).
    DeMets D; Wittes J; Siegel J
    Clin Trials; 2013 Oct; 10(5):680-9. PubMed ID: 24130200
    [No Abstract]   [Full Text] [Related]  

  • 39. University of Pennsylvania 8th annual conference on statistical issues in clinical trials: Pragmatic clinical trials (morning panel).
    Dodd LE; Lantos JD; Pinheiro J
    Clin Trials; 2016 Oct; 13(5):493-503. PubMed ID: 27430711
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigating Subgroup Effects in Randomized Clinical Trials.
    Dehbi HM; Hackshaw A
    J Clin Oncol; 2017 Jan; 35(2):253-254. PubMed ID: 28056207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.